Allworth Financial’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.05K | Buy |
65
+21
| +48% | +$662 | ﹤0.01% | 3680 |
|
2025
Q1 | $1.38K | Sell |
44
-13
| -23% | -$408 | ﹤0.01% | 3342 |
|
2024
Q4 | $2.18K | Buy |
57
+17
| +43% | +$649 | ﹤0.01% | 3122 |
|
2024
Q3 | $1.25K | Hold |
40
| – | – | ﹤0.01% | 3141 |
|
2024
Q2 | $1.21K | Hold |
40
| – | – | ﹤0.01% | 3103 |
|
2024
Q1 | $1.37K | Sell |
40
-371
| -90% | -$12.7K | ﹤0.01% | 2970 |
|
2023
Q4 | $11.9K | Sell |
411
-100
| -20% | -$2.89K | ﹤0.01% | 1912 |
|
2023
Q3 | $14.1K | Buy |
511
+100
| +24% | +$2.76K | ﹤0.01% | 1723 |
|
2023
Q2 | $12.4K | Buy |
411
+323
| +367% | +$9.71K | ﹤0.01% | 1791 |
|
2023
Q1 | $3.19K | Buy |
88
+28
| +47% | +$1.02K | ﹤0.01% | 2214 |
|
2022
Q4 | $2.14K | Buy |
60
+20
| +50% | +$713 | ﹤0.01% | 2219 |
|
2022
Q3 | $1K | Hold |
40
| – | – | ﹤0.01% | 2505 |
|
2022
Q2 | $1K | Hold |
40
| – | – | ﹤0.01% | 2264 |
|
2022
Q1 | $1K | Hold |
40
| – | – | ﹤0.01% | 2023 |
|
2021
Q4 | $1K | Hold |
40
| – | – | ﹤0.01% | 1861 |
|
2021
Q3 | $1K | Hold |
40
| – | – | ﹤0.01% | 1802 |
|
2021
Q2 | $1K | Hold |
40
| – | – | ﹤0.01% | 1497 |
|
2021
Q1 | $1K | Hold |
40
| – | – | ﹤0.01% | 1430 |
|
2020
Q4 | $1K | Hold |
40
| – | – | ﹤0.01% | 1293 |
|
2020
Q3 | $1K | Hold |
40
| – | – | ﹤0.01% | 1130 |
|
2020
Q2 | $1K | Sell |
40
-1
| -2% | -$25 | ﹤0.01% | 1135 |
|
2020
Q1 | $1K | Hold |
41
| – | – | ﹤0.01% | 1184 |
|
2019
Q4 | $1K | Hold |
41
| – | – | ﹤0.01% | 1011 |
|
2019
Q3 | $1K | Hold |
41
| – | – | ﹤0.01% | 918 |
|
2019
Q2 | $1K | Hold |
41
| – | – | ﹤0.01% | 906 |
|
2019
Q1 | $1K | Buy |
41
+1
| +3% | +$24 | ﹤0.01% | 923 |
|
2018
Q4 | $1K | Hold |
40
| – | – | ﹤0.01% | 829 |
|
2018
Q3 | $2K | Hold |
40
| – | – | ﹤0.01% | 808 |
|
2018
Q2 | $2K | Hold |
40
| – | – | ﹤0.01% | 828 |
|
2018
Q1 | $2K | Buy |
+40
| New | +$2K | ﹤0.01% | 723 |
|